CL

Crv, LLC

Concentrated strategyQuality / disciplined sizingLong-term holder

Total reported value

$1.6M

Reporting period: 2022-09-30 · Number of holdings: 3

CRV, LLC disclosed 3 holdings in its latest 13F filing for the period ending 2022-09-30, with total reported value of $1.6M and a quarterly turnover rate of 0.0%.

Browse other institutions with under $100M AUMBrowse other institutions starting with "C"

Personality snowflake

Concentration
100
Portfolio Stability
0
Momentum/Contrarian
50
Sector conviction
0
Diversification
6
Sizing Uniformity
91.5

Recent moves

No holding changes this quarter

Holdings Map

New buyAddUnchangedTrim

Top 10 holdings by weight

Full holdings list this quarter

#TickerIssuerAsset SubclassWeightWeight ChangeShares Change4Q Trend
1FSLYFastly INC - Class AStock-Tech58.47%
2BBIOBridgeBio Pharma, Inc.Stock-Healthcare38.91%
3NXDRNextdoor Holdings INCStock-Other2.62%

Holding changes this quarter

Position changes disclosed by Crv, LLC for the quarter ending 2022-09-30, including ticker, issuer, weight change, shares change, and action
#TickerIssuerWeight ChangeShares ChangeAction

FAQ

What is Crv, LLC and what type of investor is it?
Crv, LLC is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2022-09-30), the firm manages a tracked equity portfolio valued at approximately $1.6M, spread across 3 disclosed positions.
What are Crv, LLC's largest equity positions?
Based on the latest 13F filing, Crv, LLC's top holdings by market value are: 1. Fastly INC - Class A (FSLY) — $915.0K (58.5%) 2. BridgeBio Pharma, Inc. (BBIO) — $609.0K (38.9%) 3. Nextdoor Holdings INC (NXDR) — $41.0K (2.6%)
What changes did Crv, LLC make in its most recent portfolio filing?
No notable portfolio changes were recorded for Crv, LLC in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Crv, LLC focus on?
Crv, LLC is concentrated in the following sectors based on its current disclosed equity portfolio: • Information Technology: 60.0% • Health Care: 40.0%